{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T03:53:47Z","timestamp":1792122827165,"version":"4.4.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology Letters"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.toxlet.2026.111911","type":"journal-article","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T15:12:58Z","timestamp":1779376378000},"page":"111911","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["A full thickness in vitro model of human skin for the penetration of highly toxic VX and the evaluation of different decontaminants"],"prefix":"10.1016","volume":"421","author":[{"given":"Gabriele","family":"Horn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelie","family":"Schwab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franz","family":"Worek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timo","family":"Wille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Steinritz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niko","family":"Amend","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.toxlet.2026.111911_bib1","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/nyas.14336","article-title":"Diagnostics and treatment of nerve agent poisoning-current status and future developments","volume":"1479","author":"Amend","year":"2020","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"1-2","key":"10.1016\/j.toxlet.2026.111911_bib2","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.tox.2006.04.030","article-title":"Analysis of inhibition, reactivation and aging kinetics of highly toxic organophosphorus compounds with human and pig acetylcholinesterase","volume":"224","author":"Aurbek","year":"2006","journal-title":"Toxicology"},{"issue":"7","key":"10.1016\/j.toxlet.2026.111911_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics17070936","article-title":"Transdermal drug delivery systems: methods for enhancing skin permeability and their evaluation","volume":"17","author":"Bakhrushina","year":"2025","journal-title":"Pharmaceutics"},{"issue":"35","key":"10.1016\/j.toxlet.2026.111911_bib4","doi-asserted-by":"crossref","first-page":"5831","DOI":"10.1002\/ejoc.201601053","article-title":"Pathways for the reactions between neurotoxic organophosphorus compounds and oximes or hydroxamic acids","volume":"2016","author":"Bierwisch","year":"2016","journal-title":"Eur. J. Org. Chem."},{"issue":"3","key":"10.1016\/j.toxlet.2026.111911_bib5","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1177\/0960327108090269","article-title":"Comparison of selected skin decontaminant products and regimens against VX in domestic swine","volume":"27","author":"Bjarnason","year":"2008","journal-title":"Hum. & Exp. Toxicol."},{"key":"10.1016\/j.toxlet.2026.111911_bib6","series-title":"Chemical Warfare Toxicology, Volume 1: Fundamental aspects","first-page":"1","article-title":"Development, Historical Use and Properties of Chemical Warfare Agents","author":"Black","year":"2016"},{"issue":"10","key":"10.1016\/j.toxlet.2026.111911_bib7","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1007\/s00204-023-03574-5","article-title":"Catch-up\u201d therapy: combining antidotal treatment with dermal application of AHA following percutaneous VX poisoning in the domestic swine","volume":"97","author":"Bloch-Shilderman","year":"2023","journal-title":"Arch. Toxicol."},{"issue":"1","key":"10.1016\/j.toxlet.2026.111911_bib8","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3109\/15569527.2010.515280","article-title":"Efficacy studies of Reactive Skin Decontamination Lotion, M291 Skin Decontamination Kit, 0.5% bleach, 1% soapy water, and Skin Exposure Reduction Paste Against Chemical Warfare Agents, part 1: guinea pigs challenged with VX","volume":"30","author":"Braue","year":"2011","journal-title":"Cutan. Ocul. Toxicol."},{"issue":"6","key":"10.1016\/j.toxlet.2026.111911_bib9","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1002\/jat.4251","article-title":"Efficacy of water-only or soap and water skin decontamination of chemical warfare agents or simulants using in vitro human models: a systematic review","volume":"42","author":"Chiang","year":"2022","journal-title":"Journal applied toxicology JAT"},{"key":"10.1016\/j.toxlet.2026.111911_bib10","series-title":"Handbook of Toxicology of chemical warefare agents","first-page":"1233","article-title":"Rapid decontamination of chemical warfare agents from skin","author":"Clarkson","year":"2020"},{"key":"10.1016\/j.toxlet.2026.111911_bib11","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.tiv.2018.08.003","article-title":"Effect of aqueous dilution on the absorption of the nerve agent VX through skin in vitro","volume":"53","author":"Dalton","year":"2018","journal-title":"Toxicol. vitro Int. J. Published Assoc. BIBRA"},{"key":"10.1016\/j.toxlet.2026.111911_bib12","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","article-title":"A new and rapid colorimetric determination of acetylcholinesterase activity","volume":"7","author":"Ellman","year":"1961","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.toxlet.2026.111911_bib13","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1432-1033.1984.tb08079.x","article-title":"Kinetics for the inhibition of acetylcholinesterase from the electric eel by some organophosphates and carbamates","volume":"140","author":"Forsberg","year":"1984","journal-title":"Eur. J. Biochem."},{"issue":"3","key":"10.1016\/j.toxlet.2026.111911_bib14","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/1523-1747.ep12533356","article-title":"Percutaneous absorption on the relevance of in vitro data","volume":"64","author":"Franz","year":"1975","journal-title":"J. Invest. Dermatol."},{"issue":"2","key":"10.1016\/j.toxlet.2026.111911_bib15","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/jat.4689","article-title":"Characterization of the in vitro penetration and first-pass metabolism of genistein and daidzein using human and pig skin explants and Phenion full-thickness skin models","volume":"45","author":"G\u00e9ni\u00e8s","year":"2025","journal-title":"Journal applied toxicology JAT"},{"issue":"15","key":"10.1016\/j.toxlet.2026.111911_bib16","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1021\/bi00739a026","article-title":"Recording spectrophotometric method for determination of dissociation and phosphorylation constants for the inhibition of acetylcholinesterase by organophosphates in the presence of substrate","volume":"12","author":"Hart","year":"1973","journal-title":"Biochemistry"},{"key":"10.1016\/j.toxlet.2026.111911_bib17","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.toxlet.2024.04.003","article-title":"Inhibition kinetics of acetylcholinesterase and butyrylcholinesterase from various species by 2-(2-cresyl)-4H-1,3,2-benzodioxaphosphorin-2-oxide (CBDP)","volume":"396","author":"Horn","year":"2024","journal-title":"Toxicol. Lett."},{"issue":"8","key":"10.1016\/j.toxlet.2026.111911_bib18","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.1007\/s00204-025-04059-3","article-title":"Concentration-time profiles of the nerve agent VX and the pesticide parathion in five different cell culture plates","volume":"99","author":"Horn","year":"2025","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.toxlet.2026.111911_bib19","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.cbi.2016.02.001","article-title":"The impact of skin decontamination on the time window for effective treatment of percutaneous VX exposure","volume":"267","author":"Joosen","year":"2017","journal-title":"Chem. -Biol. Interact."},{"issue":"1","key":"10.1016\/j.toxlet.2026.111911_bib20","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.cbi.2012.10.002","article-title":"Timing of decontamination and treatment in case of percutaneous VX poisoning: a mini review","volume":"203","author":"Joosen","year":"2013","journal-title":"Chem. -Biol. Interact."},{"issue":"7","key":"10.1016\/j.toxlet.2026.111911_bib21","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1007\/s00204-023-03521-4","article-title":"Evidence of nerve agent VX exposure in rat plasma by detection of albumin-adducts in vitro and in vivo","volume":"97","author":"Kranawetvogl","year":"2023","journal-title":"Arch. Toxicol."},{"issue":"_1A","key":"10.1016\/j.toxlet.2026.111911_bib22","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1177\/026119290403201s12","article-title":"Full Thickness EpiDerm: a dermal-epidermal skin model to study epithelial-mesenchymal interactions","volume":"32","author":"Kubilus","year":"2004","journal-title":"Altern. Lab. Anim. ATLA"},{"issue":"6","key":"10.1016\/j.toxlet.2026.111911_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics16060817","article-title":"Progress in Topical and Transdermal Drug Delivery Research-Focus on Nanoformulations","volume":"16","author":"Lunter","year":"2024","journal-title":"Pharmaceutics"},{"issue":"2","key":"10.1016\/j.toxlet.2026.111911_bib24","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.tiv.2009.08.019","article-title":"Evaluation of EpiDerm full thickness-300 (EFT-300) as an in vitro model for skin irritation: studies on aliphatic hydrocarbons","volume":"24","author":"Mallampati","year":"2010","journal-title":"Toxicology vitro international journal published association BIBRA"},{"issue":"1","key":"10.1016\/j.toxlet.2026.111911_bib25","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0163-7258(93)90066-M","article-title":"Organophosphate poisoning","volume":"58","author":"Marrs","year":"1993","journal-title":"Pharmacol. & Ther."},{"issue":"2","key":"10.1016\/j.toxlet.2026.111911_bib26","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.toxlet.2013.03.005","article-title":"Evaluation of in vitro absorption, decontamination and desorption of organophosphorous compounds from skin and synthetic membranes","volume":"219","author":"Mircioiu","year":"2013","journal-title":"Toxicol. Lett."},{"issue":"9","key":"10.1016\/j.toxlet.2026.111911_bib27","doi-asserted-by":"crossref","first-page":"807","DOI":"10.3109\/15563650.2012.720986","article-title":"vivo decontamination of the nerve agent VX using the domestic swine model","volume":"50","author":"Misik","year":"2012","journal-title":"Clinical toxicology (Philadelphia Pa. )"},{"issue":"7","key":"10.1016\/j.toxlet.2026.111911_bib28","doi-asserted-by":"crossref","first-page":"520","DOI":"10.3109\/15376516.2012.686535","article-title":"vitro skin permeation and decontamination of the organophosphorus pesticide paraoxon under various physical conditions\u2014evidence for a wash-in effect","volume":"22","author":"Misik","year":"2012","journal-title":"Toxicol. Mech. Methods"},{"issue":"12","key":"10.1016\/j.toxlet.2026.111911_bib29","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1080\/15287390600870874","article-title":"vitro dermal absorption of methyl salicylate, ethyl parathion, and malathion: first responder safety","volume":"70","author":"Moody","year":"2007","journal-title":"J. Toxicol. Environ. Health Part A"},{"key":"10.1016\/j.toxlet.2026.111911_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120689","article-title":"Towards catch-up therapy: evaluation of nucleophilic active pharmaceutical ingredients for the treatment of percutaneous VX poisoning, in-vial and in-vitro studies","volume":"603","author":"Nahum","year":"2021","journal-title":"Int. J. Pharm."},{"issue":"9","key":"10.1016\/j.toxlet.2026.111911_bib31","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s00403-007-0788-z","article-title":"Defense against dermal exposures is only skin deep: significantly increased penetration through slightly damaged skin","volume":"299","author":"Nielsen","year":"2007","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.toxlet.2026.111911_bib32","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.mrgentox.2018.01.003","article-title":"Validation of the 3D Skin Comet assay using full thickness skin models: Transferability and reproducibility","volume":"827","author":"Reisinger","year":"2018","journal-title":"Mutat. Res. Genet. Toxicol. Environ. Mutagen."},{"key":"10.1016\/j.toxlet.2026.111911_bib33","series-title":"Chemical Warfare Toxicology, Volume 1: Fundamental aspects","first-page":"81","article-title":"Toxicology of Organophosphorus Nerve Agents","author":"Rice","year":"2016"},{"issue":"3","key":"10.1016\/j.toxlet.2026.111911_bib34","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0300-483X(91)90028-Y","article-title":"Efficacy of an oximate-based skin decontaminant against organophosphate nerve agents determined in vivo and in vitro","volume":"67","author":"Sawyer","year":"1991","journal-title":"Toxicology"},{"key":"10.1016\/j.toxlet.2026.111911_bib35","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.toxlet.2025.01.002","article-title":"A simple acetylcholinesterase inhibition assay for the quantification of the nerve agent VX: Application in a Franz cell model with rat skin and various decontaminants","volume":"404","author":"Schwab","year":"2025","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.toxlet.2026.111911_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2026.112028","article-title":"A three-dimensional, bioartificial human skin equivalent as an innovative technology for studying the decontamination of the nerve agent VX","author":"Schwab","year":"2026","journal-title":"Chem. -Biol. Interact."},{"issue":"10","key":"10.1016\/j.toxlet.2026.111911_bib37","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.2174\/138920112802273191","article-title":"Reactive skin decontamination lotion (RSDL) for the decontamination of chemical warfare agent (CWA) dermal exposure","volume":"13","author":"Schwartz","year":"2012","journal-title":"Curr. Pharm. Biotechnol."},{"issue":"2","key":"10.1016\/j.toxlet.2026.111911_bib38","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1177\/0960327107071866","article-title":"Skin decontamination of mustards and organophosphates: comparative efficiency of RSDL and Fuller\u2019s earth in domestic swine","volume":"26","author":"Taysse","year":"2007","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/j.toxlet.2026.111911_bib39","series-title":"Chemical Warfare Toxicology, Volume 2: Management of Poisoning","first-page":"1","article-title":"Treatment of Nerve Agent Poisoning","author":"Thiermann","year":"2016"},{"issue":"6","key":"10.1016\/j.toxlet.2026.111911_bib40","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1080\/15563650.2025.2501266","article-title":"Approaches to the treatment of nerve agent poisoning with oximes - from experimental studies to the intensive care unit","volume":"63","author":"Thiermann","year":"2025","journal-title":"Clinical toxicology (Philadelphia Pa. )"},{"key":"10.1016\/j.toxlet.2026.111911_bib41","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.tiv.2016.01.003","article-title":"vitro human skin penetration model for organophosphorus compounds with different physicochemical properties","volume":"32","author":"Thors","year":"2016","journal-title":"Toxicology vitro international journal published association BIBRA"},{"key":"10.1016\/j.toxlet.2026.111911_bib42","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.cbi.2017.06.002","article-title":"Comparison of skin decontamination efficacy of commercial decontamination products following exposure to VX on human skin","volume":"273","author":"Thors","year":"2017","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.toxlet.2026.111911_bib43","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.toxlet.2017.02.001","article-title":"RSDL decontamination of human skin contaminated with the nerve agent VX","volume":"269","author":"Thors","year":"2017","journal-title":"Toxicol. Lett."},{"issue":"2","key":"10.1016\/j.toxlet.2026.111911_bib44","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1080\/15569527.2021.1902342","article-title":"Efficient agent degradation within skin is important for decontamination of percutaneously exposed VX","volume":"40","author":"Thors","year":"2021","journal-title":"Cutan. Ocul. Toxicol."},{"key":"10.1016\/j.toxlet.2026.111911_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2020.109135","article-title":"Improved skin decontamination efficacy for the nerve agent VX","volume":"325","author":"Thors","year":"2020","journal-title":"Chem. -Biol. Interact."},{"issue":"9","key":"10.1016\/j.toxlet.2026.111911_bib46","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1002\/jat.4627","article-title":"Immediate dry decontamination using efficient absorbent materials is beneficial following skin exposure to low-volatile toxic chemicals","volume":"44","author":"Thors","year":"2024","journal-title":"Journal applied toxicology JAT"},{"key":"10.1016\/j.toxlet.2026.111911_bib47","unstructured":"U.S. Army Medical Research Institute of Chemical Defense, 2014. Medical management of chemical causalties handbook, Chemical Causualty Care Division, Aberdeen Proving Ground, Maryland."},{"issue":"1","key":"10.1016\/j.toxlet.2026.111911_bib48","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0041-008X(03)00216-3","article-title":"Toxicokinetics of the nerve agent (+\/-)-VX in anesthetized and atropinized hairless guinea pigs and marmosets after intravenous and percutaneous administration","volume":"191","author":"van der Schans","year":"2003","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"1-2","key":"10.1016\/j.toxlet.2026.111911_bib49","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0009-8981(99)00144-8","article-title":"Improved determination of acetylcholinesterase activity in human whole blood","volume":"288","author":"Worek","year":"1999","journal-title":"Clin. Chim. Acta Int. J. Clin. Chem."},{"issue":"2","key":"10.1016\/j.toxlet.2026.111911_bib50","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.pharmthera.2013.04.009","article-title":"The value of novel oximes for treatment of poisoning by organophosphorus compounds","volume":"139","author":"Worek","year":"2013","journal-title":"Pharmacol. & Ther."},{"issue":"11","key":"10.1016\/j.toxlet.2026.111911_bib51","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1016\/j.bcp.2004.07.038","article-title":"Kinetic analysis of interactions between human acetylcholinesterase, structurally different organophosphorus compounds and oximes","volume":"68","author":"Worek","year":"2004","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.toxlet.2026.111911_bib52","series-title":"Chemical Warfare Toxicology, Volume 2: Management of Poisoning","first-page":"157","article-title":"Clinical and Laboratory Diagnosis of Chemical Warfare Agent Exposure","author":"Worek","year":"2016"}],"container-title":["Toxicology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378427426000949?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378427426000949?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T10:41:57Z","timestamp":1780742517000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378427426000949"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":52,"alternative-id":["S0378427426000949"],"URL":"https:\/\/doi.org\/10.1016\/j.toxlet.2026.111911","relation":{},"ISSN":["0378-4274"],"issn-type":[{"value":"0378-4274","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A full thickness in vitro model of human skin for the penetration of highly toxic VX and the evaluation of different decontaminants","name":"articletitle","label":"Article Title"},{"value":"Toxicology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxlet.2026.111911","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111911"}}